Search results
Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
FX Empire via Yahoo Finance· 5 hours agoThe past five days have been a rollercoaster for Novavax investors, as the share price of the...
Novavax Stock Just Tripled. Is It Too Late to Buy?
The Motley Fool via AOL· 6 hours agoAnd it also offers Novavax the opportunity to benefit from the pharma giant's massive commercial infrastructure -- something that should help theNovavax
Novavax (NASDAQ:NVAX) PT Raised to $10.00 at TD Cowen
ETF DAILY NEWS· 11 hours agoNovavax (NASDAQ:NVAX – Get Free Report) had its target price upped by equities research analysts at TD Cowen from $5.00 to $10.00 in a report released on Monday, Benzinga ...
Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal
InvestorPlace· 5 days agoNovavax (NASDAQ:NVAX) stock has more than doubled today and is up more than 120% at the time of this...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? | The Motley Fool
The Motley Fool· 1 day agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 1 day agoNovavax stock isn't a buy. Savvy investors are encouraged to buy a stock after it breaks out of a...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance via AOL· 5 days agoWhile Novavax's vaccine did finally reach the market in mid-2022 targeting the booster market, it...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 5 days agoDriving the news: Novavax will receive an upfront payment of $500 million and up to $700 million in...
3 Meme Stocks That Are Likely to Crater in 2024
InvestorPlace· 1 day agoMeme stocks have the potential to completely change the portfolio health even with a limited exposure of 5% to 10%. At the same time, there are meme...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 5 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...